Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the ???Cholangiocarcinoma??? committee of the Italian Association for the Study of Liver disease, Digestive and Liver Disease, vol.43, issue.1, pp.60-65, 2011. ,
DOI : 10.1016/j.dld.2010.05.002
Trends in the incidence of primary liver and biliary tract cancers in England and Wales, 1971. ,
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer, Annals of Oncology, vol.7, issue.6, pp.593-600, 1996. ,
DOI : 10.1093/oxfordjournals.annonc.a010676
Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer, British Journal of Cancer, vol.4, issue.9, pp.1650-1654, 2005. ,
DOI : 10.1136/gut.48.6.816
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial, Annals of Oncology, vol.15, issue.3, pp.478-483, 2004. ,
DOI : 10.1093/annonc/mdh096
A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial, European Journal of Cancer, vol.41, issue.3, pp.398-403, 2005. ,
DOI : 10.1016/j.ejca.2004.10.026
Oxaliplatin as First-Line Treatment in Inoperable Biliary Tract Carcinoma, Oncology, vol.70, issue.4, pp.280-284, 2006. ,
DOI : 10.1159/000096249
Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials, British Journal of Cancer, vol.18, issue.6, pp.896-902, 2007. ,
DOI : 10.1038/sj.bjc.6690452
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study, British Journal of Cancer, vol.51, issue.6, pp.862-867, 2008. ,
DOI : 10.1093/annonc/mdl955
Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer, British Journal of Cancer, vol.22, issue.7, pp.848-852, 2006. ,
DOI : 10.1038/sj.bjc.6603334
A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer, Cancer Chemotherapy and Pharmacology, vol.99, issue.6, pp.497-502, 2010. ,
DOI : 10.1007/s00280-009-1055-0
Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial, Cancer Chemotherapy and Pharmacology, vol.16, issue.4, pp.641-647, 2010. ,
DOI : 10.1007/s00280-009-1069-7
Supraadditive effect of 2 ??? ,2 ??? -difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines, Cancer Chemotherapy and Pharmacology, vol.44, issue.2, pp.117-123, 1999. ,
DOI : 10.1007/s002800050955
Best Supportive Care Compared With Chemotherapy for Unresectable Gall Bladder Cancer: A Randomized Controlled Study, Journal of Clinical Oncology, vol.28, issue.30, pp.4581-4586, 2010. ,
DOI : 10.1200/JCO.2010.29.3605
Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial, Lung Cancer, vol.41, issue.3, pp.321-331, 2003. ,
DOI : 10.1016/S0169-5002(03)00233-2
Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non???Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group, Journal of Clinical Oncology, vol.23, issue.33, pp.8380-8388, 2005. ,
DOI : 10.1200/JCO.2005.01.2781
Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer ???Unfit??? for Cisplatin-Based Chemotherapy: Phase II???Results of EORTC Study 30986, Journal of Clinical Oncology, vol.27, issue.33, pp.5634-5639, 2009. ,
DOI : 10.1200/JCO.2008.21.4924
Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study, HPB, vol.12, issue.6, pp.418-426, 2010. ,
DOI : 10.1111/j.1477-2574.2010.00197.x
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial, The Lancet Oncology, vol.15, issue.8, pp.819-847, 2014. ,
DOI : 10.1016/S1470-2045(14)70212-8
Second-line chemotherapy with capecitabine (CAP) and oxaliplatin (OX) in patients with pancreatic or biliary tree adenocarcinoma (ADC) 2011 Gastrointestinal Cancers Symposium [abstract 308], J Clin Oncol, vol.29, p.4, 2011. ,
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy, BMC Gastroenterology, vol.29, issue.1, p.143, 2014. ,
DOI : 10.1200/JCO.2010.32.1752
URL : https://hal.archives-ouvertes.fr/inserm-01096384